Rami Komrokji

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Rami Komrokji
Sep 8, 2024, 06:13 | Societies
23 Posts Not To Miss From SOHO2024
The twelfth annual meeting of the Society of Hematologic Oncology (SOHO 2024) was held from…
Sep 4, 2024, 17:52 | Blog
Ryan Fitzpatrick: The 6th annual MPN MDS EU Focus meeting by MD Education
Ryan Fitzpatrick, CEO and Founder, MD Education, shared a post on LinkedIn: "A great 2 day…
Jul 15, 2024, 21:23 | Insight
Herculean effort on risk prediction model for clonal cytopenias
UChicago Leukemia Program shared a post on X about a recent paper by Zhuoer Xie et…
Jul 14, 2024, 07:11 | Blog
Naveen Pemmaraju: Nitin Jain and Rami Komrokji kick off the US AML-ALL Focus meeting
Naveen Pemmaraju shared a post on X:   . "Superb talks by Nitin Jain on Highlights…
Jul 9, 2024, 00:57 | Insight
Talha Badar: Outcome after stopping venetoclax and azacitidine
Talha Badar shared on X: “American Journal of Hematology, Blood Research Journal, Wiley Online Library.…
Jul 2, 2024, 04:25 | OncoDaily Pulse
OncoDaily Party and Yvonne Award 2024 Photos - Part 2
On May 31st, 2024, during the ASCO Annual Meeting in Chicago, OncoDaily hosted the inaugural…
Jun 7, 2024, 12:04 | Drugs
Rami Komrokji: Imetelstat approved for MDS patients
Rami Komrokji, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Center, shared a…
May 13, 2024, 13:48 | Blog
Rami Komrokji: Combining GenoMed and Moffitt database
Rami Komrokji, Vice chair of the Malignant Hematology Department and the head of the Leukemia…
May 12, 2024, 01:40 | Insight
Justin Watts: A significant portion of patients at the extremes of older age (80-90) still derive benefit from the VEN-HMA regimen
Justin Watts et al. report that standard of care treatment for acute myeloid leukemia extends…
May 7, 2024, 10:51 | Blog
Maximilian Stahl: I’ll be at the Oncology Symposia in Conjunction With the 2024 ASCO Annual Meeting
Maximilian Stahl, Attending Physician in the Department of Medical Oncology at Dana-Farber Cancer Institute, shared…
May 7, 2024, 01:32 | Blog
AML session at HOPLive24 - Blood Cancers Today
Blood Cancers Today shared on X/Twitter: "Up next: Naval Daver, Sanam Loghavi, Rami Komrokji, and Mikkael…
Apr 28, 2024, 16:18 | Societies
OncoDaily Leukemia Conference: Day 2
"The best specialists in the field of hematology and numerous interesting and informative reports. The…
Apr 8, 2024, 15:14 | Blog
Uma Borate: Should luspatercept be used as front-line therapy in RS- low-risk transfusion-dependent MDS?
Uma Borate, Acute Leukemia Translation Lead, Associate Professor at OHSU, shared on X: "Fantastic start…
Feb 9, 2024, 05:19 | Insight
Rami Komrokji: Our paper addressing pattern of lower risk myelodysplastic syndrome progression
Quoting Rami Komrokji, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Centre and…
Oct 1, 2023, 12:32 | Blog
Rami Komrokji: What an honor to co-chair the Society of Hematologic Oncology (SOHO) MENA23 in Beirut.
Rami Komrokji, Vice Chair - Malignant Hematology Department at the H Lee Moffitt Cancer Center,…
Sep 27, 2023, 17:41 | Blog
Ryan Fitzpatrick: Phenomenal 2 day CME meeting with 32 world renowned clinicians in Bratislava, Slovakia for the 5th annual MPN-MDS EU Focus meeting.
Ryan Fitzpatrick, CEO and founder of MD education, recently shared on Twitter: "Phenomenal 2 day CME…
Sep 17, 2023, 18:34 | Blog
Rami Komrokji: Honored to kick off the EU MPN-MDS meeting in Bratislava co-chairing with professor Alessandro Vannucchi.
Quoting Rami Komrokji, Vice Chair of the Malignant Haematology Department at Moffitt Cancer Centre and…
Sep 6, 2023, 17:03 | Insight
Rami Komrokji: All high risk MDS patients should be considered for transplant
Hem-Onc Fellows Network shared on Twitter (X): "Dr. Rami Komrokji from Moffitt Cancer Center presenting…
All: 18 Posts: 1 - 100
Special Coverage